Live to die another day: novel insights may explain the pathophysiology behind smoker’s paradox in SARS-CoV-2 infection

[1]  M. Mahmoudzadeh,et al.  Effect of Nicotine on Immune System Function , 2022, Advanced pharmaceutical bulletin.

[2]  Haide Chen,et al.  Socializing with Smoker and Social Smoking Behavior among Chinese Male Smokers with Low Nicotine Dependence: The Mediating Roles of Belief of Smoking Rationalization and Smoker Identity , 2022, International journal of environmental research and public health.

[3]  K. Papadopoulos,et al.  A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children , 2022, Human Cell.

[4]  M. Gissler,et al.  New theory about the pathophysiology of preeclampsia derived from the paradox of positive effects of maternal smoking , 2022, Journal of hypertension.

[5]  G. Vist,et al.  Polycyclic aromatic hydrocarbons (PAHs) may explain the paradoxical effects of cigarette use on preeclampsia (PE). , 2022, Toxicology.

[6]  K. Papadopoulos,et al.  Too hard to die: Exercise training mediates specific and immediate SARS-CoV-2 protection , 2022, World journal of virology.

[7]  Tobacco and nicotine use , 2022, Nature Reviews Disease Primers.

[8]  Megan E. Piper,et al.  Tobacco and nicotine use , 2022, Nature Reviews Disease Primers.

[9]  N. Nalivaeva,et al.  Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation , 2022, Peptides.

[10]  G. Citerio,et al.  Nitric oxide: Clinical applications in critically ill patients. , 2022, Nitric oxide : biology and chemistry.

[11]  D. Ivashchenko,et al.  Allele С (rs5186) of at1r is associated with the severity of COVID-19 in the Ukrainian population , 2022, Infection, Genetics and Evolution.

[12]  Yuval Arbel,et al.  Can smoking prevalence explain COVID-19 indicators (cases, mortality, and recovery)? A comparative study in OECD countries , 2020, Environmental Science and Pollution Research.

[13]  K. Papadopoulos,et al.  Genetic polymorphisms affecting nitric oxide and β-cytokine pathways may contribute to increased COVID-19 mortality in schizophrenia , 2021, Asian Journal of Psychiatry.

[14]  P. Purohit,et al.  MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19 , 2021, Meta Gene.

[15]  F. Quintana,et al.  AHR signaling is induced by infection with coronaviruses , 2021, Nature Communications.

[16]  Y. Tesfaigzi,et al.  Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease , 2021, BMC Pulmonary Medicine.

[17]  Jun Kobayashi.  Lifestyle-mediated nitric oxide boost to prevent SARS-CoV-2 infection: A perspective , 2021, Nitric Oxide.

[18]  D. Ojcius,et al.  Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells , 2021, International journal of molecular sciences.

[19]  Y. Kuo,et al.  Smoking and risk of COVID-19 hospitalization , 2021, Respiratory Medicine.

[20]  F. Bianchi,et al.  Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey , 2021, JMIR Public Health and Surveillance.

[21]  M. Sayadi,et al.  The Impact of Smoking on Clinical Outcomes after Percutaneous Coronary Intervention in Women Compared to Men , 2021, Journal of interventional cardiology.

[22]  H. Bono,et al.  Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal , 2021, Scientific Reports.

[23]  Kaifeng Xu,et al.  Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells , 2021, Frontiers of Medicine.

[24]  E. Lazartigues,et al.  Angiotensin Type 1 Receptor-Dependent Internalization of SARS-CoV-2 by Angiotensin-Converting Enzyme 2 , 2021, Hypertension.

[25]  B. Dautzenberg,et al.  Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study , 2021, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[26]  S. Ristić,et al.  Association between the ACE-I/D polymorphism and nicotine dependence amongst patients with lung cancer. , 2020, Biomedical reports.

[27]  C. Tascini,et al.  The Paradox of the Low Prevalence of Current Smokers Among Covid-19 Patients Hospitalized in Non-Intensive Care Wards: Results From an Italian Multicenter Case-Control Study , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[28]  J. Lennerstrand,et al.  Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro , 2020, Redox Biology.

[29]  Urvish K. Patel,et al.  Is there a smoker’s paradox in COVID-19? , 2020, BMJ Evidence-Based Medicine.

[30]  G. H. Oliveira-Paula,et al.  Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response , 2020, Expert opinion on drug metabolism & toxicology.

[31]  V. Lagente,et al.  Alteration of immunophenotype of human macrophages and monocytes after exposure to cigarette smoke , 2020, Scientific Reports.

[32]  Zhiyong Wu,et al.  Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients , 2020, Critical Care.

[33]  K. Farsalinos,et al.  Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis , 2020, Therapeutic advances in chronic disease.

[34]  P. Carmeliet,et al.  COVID-19: the vasculature unleashed , 2020, Nature Reviews Immunology.

[35]  J. Tardif,et al.  Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. , 2020, European journal of preventive cardiology.

[36]  O. Perski,et al.  The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 5) , 2020, Qeios.

[37]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[38]  C. Vardavas,et al.  COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.

[39]  A. Alkhedaide.  Tobacco smoking causes secondary polycythemia and a mild leukocytosis among heavy smokers in Taif City in Saudi Arabia , 2019, Saudi journal of biological sciences.

[40]  F. Torres-Juárez,et al.  Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis , 2020, Clinical and experimental immunology.

[41]  H. Ko,et al.  The effect of outdoor smoking ban: Evidence from Korea. , 2019, Health economics.

[42]  G. Joos,et al.  The role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD , 2019, Mucosal Immunology.

[43]  Guangbiao Zhou.  Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer , 2019, Cancer biology & medicine.

[44]  A. Budaj,et al.  Smoking and cardiovascular diseases - is there more paradox than expected? , 2019, Polish archives of internal medicine.

[45]  Zhe Hong,et al.  Combined effects of cigarette smoking, alcohol drinking and eNOS Glu298Asp polymorphism on blood pressure in Chinese male hypertensive subjects , 2019, Tobacco induced diseases.

[46]  Ramotowski,et al.  Smoking and cardiovascular diseases: paradox greater than expected? , 2019 .

[47]  V. Kutala,et al.  Impact of eNOS 27-bp VNTR (4b/a) gene polymorphism with the risk of Systemic Lupus Erythematosus in south Indian subjects. , 2018, Gene.

[48]  W. Feleszko,et al.  Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review , 2018, International journal of environmental research and public health.

[49]  Lyanne M. Kieneker,et al.  Active Smoking and Hematocrit and Fasting Circulating Erythropoietin Concentrations in the General Population , 2018, Mayo Clinic proceedings.

[50]  S. Ristić,et al.  The insertion/deletion polymorphism in the angiotensin-converting enzyme gene and nicotine dependence in schizophrenia patients , 2017, Journal of Neural Transmission.

[51]  M. Obeidat,et al.  Total particulate matter concentration skews cigarette smoke's gene expression profile , 2016, ERJ Open Research.

[52]  J. Tanus-Santos,et al.  Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms. , 2016, Gene.

[53]  R. Narain,et al.  Gene therapies in clinical trials , 2016 .

[54]  P. Bundhun,et al.  Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention , 2015, Medicine.

[55]  Yingzi Zhao,et al.  Vascular nitric oxide: Beyond eNOS. , 2015, Journal of pharmacological sciences.

[56]  D. Henderson,et al.  Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. , 2015, The lancet. Psychiatry.

[57]  E. Fernández,et al.  Secondhand smoke in outdoor settings: smokers’ consumption, non-smokers’ perceptions, and attitudes towards smoke-free legislation in Spain , 2015, BMJ Open.

[58]  Charles E. Vejnar,et al.  Repression of Arginase-2 Expression in Dendritic Cells by MicroRNA-155 Is Critical for Promoting T Cell Proliferation , 2014, The Journal of Immunology.

[59]  T. Nolin,et al.  The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. , 2013, Journal of the American College of Cardiology.

[60]  M. Jeong,et al.  ‘Smoker's paradox’ in young patients with acute myocardial infarction , 2012, Clinical and experimental pharmacology & physiology.

[61]  S. Shyue,et al.  β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase , 2011, Journal of cellular physiology.

[62]  T. Länne,et al.  The association between circulating angiotensin-converting enzyme and cardiovascular risk in the elderly: a cross-sectional study , 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[63]  Office on Smoking.  How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General , 2010 .

[64]  A. Mirazimi,et al.  Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected , 2009, Virology.

[65]  Ronald G. Crystal,et al.  Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease1 , 2009, The Journal of Immunology.

[66]  I. Faraoni,et al.  miR-155 gene: a typical multifunctional microRNA. , 2009, Biochimica et biophysica acta.

[67]  A. Patzak,et al.  Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[68]  U. Förstermann,et al.  Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.

[69]  P. Maes,et al.  Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound☆ , 2004, International Journal of Infectious Diseases.

[70]  Chen Yan,et al.  Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[71]  D. Dudley,et al.  Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency: Modifiable by Cigarette Smoking , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[72]  H. Lee,et al.  Gene Polymorphisms of Endothelial Nitric Oxide Synthase and Angiotensin-converting Enzyme in Patients with Lung Cancer , 2000, Lung.

[73]  Michael Pittilo.  Cigarette smoking, endothelial injury and cardiovascular disease , 2000, International journal of experimental pathology.

[74]  G. Murrell,et al.  Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity , 2000, FEBS letters.

[75]  B. Mayer,et al.  Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. , 2000, Circulation research.

[76]  J. Ayres,et al.  Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations , 1998, Thorax.

[77]  C. Rångemark,et al.  Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers. , 1996, Clinical physiology.

[78]  R. Lassila,et al.  Enhanced activation of the renin‐angiotensin‐aldosterone system in chronic cigarette smokers: A study of monozygotic twin pairs discordant for smoking , 1988, Clinical pharmacology and therapeutics.

[79]  T. Higenbottam,et al.  Nitric oxide yields of contemporary UK, US and French cigarettes. , 1987, International journal of epidemiology.